Paige’s AI-assisted diagnostic AI applications meet the highest standards and are designed to support some of the most challenging cases cancer.

AI-Assisted Diagnostic Applications:

Paige Prostate Suite

The Paige Prostate Suite is a group of comprehensive AI-powered applications that aid in the detection and grading of prostate cancer on H&E-stained whole-slide images of prostate needle biopsies.

Paige Prostate Detect(ii) - Assists in the detection of foci suspicious for cancer
Paige Prostate Grade & Quantify* - Categorizes areas suspicious for cancer by Gleason pattern, providing a primary and secondary Gleason grade prediction, as well as a percentage and linear measurement of tumor burden
Paige Prostate Perineural Invasion (PNI)* - Aids in the detection of suspicious foci around nerve fiber, identifying the presence of PNI

Paige Breast Suite

The Paige Breast Suite is a set of AI-powered applications designed to support pathologists in the identification and classification of breast cancer on H&E-stained whole-slide images from breast biopsy and excision specimens. By pinpointing suspicious tissue and accelerating the most challenging and tedious aspects of case analysis, the Paige Breast Suite helps pathologists make more efficient and consistent clinical decisions.

Paige Breast Detect & Neoplasm* - Highlights foci suspicious for cancer and pre-cancerous neoplasms
Paige Breast Mitosis* - Identifies individual mitotic figures, locates the mitotic hotspot, and automatically calculates mitotic counts mitotic density
Paige Breast Lymph Node* - Detects foci that are suspicious for breast cancer metastasis from lymph node specimens
Her2Complete (ii) – an AI assay that can measure Her2 expression from H&E samples, including the identification of HER-2 low patients

Paige PanCancer Detect

A novel, first of its kind application that can detect regions of interest suspicious for cancer across 40 multiple organs and different tissues, including GI, GU, lung, cervix, endometrium, breast, skin, brain and rare cancer variants.
In digital workflows, can be used to prioritize cases for accelerated workflow

How pathologists are using Paige’s AI-assisted diagnostic applications

Every day, pathologists leverage Paige's AI applications to enhance their diagnostic confidence, improve workflow efficiencies, and ultimately deliver better patient care. From image analysis and decision support to workflow automation, Paige is being used to support hospitals and labs worldwide.

Prioritize cases or individual slides by identifying those suspicious for cancer
Quickly identify an area on the slide most suspicious for cancer, including hard-to-find or small malignant foci.
Automate laborious diagnostic tasks including measurement, quantification, and classification
Provide quality assurance

Seamless Integration Across Digital Pathology Platforms

Leveraging Paige’s AI open strategy, we enable seamless deployment across multiple scanners, image formats and digital pathology platforms. So whether you are using an established platform or exploring new digital IMS options, Paige will work with you to ensure a seamless AI experience and fit effortlessly into your lab workflows.

---
(ii) In the United States, Paige Prostate Detect (DEN200080) is approved for clinical use and CE-IVD marked, as detailed in the intended use https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/denovo.cfm?id=DEN200080
*CE-IVD marked. For Research Use Only (RUO) in the US. Not for use in diagnostic procedures in the US.
± For Research Use Only (RUO). Not for use in diagnostic procedures.

Paige Diagnostic AIPAIGE.AI, INC.

Paige Diagnostic AI

PAIGE.AI, INC.

Paige Diagnostic AI

PAIGE.AI, INC.

Paige Diagnostic AI
PAIGE.AI, INC.